Cardiovascular Therapeutics / 2020 / Article / Tab 1

Clinical Study

Predictive Value of Electromechanical Activation Time for In-Hospital Major Cardiac Adverse Events in Heart Failure Patients

Table 1

Comparison of demographic and baseline clinical characteristics between MACE and non-MACE groups.

MACE NonMACE P value

Age (years)55.9 ± 17.358.2 ± 15.00.506
Male14 (63.6%)92 (74.8%)0.277

Prior history
Hypertension10 (45.5%)69 (56.1%)0.356
Diabetic mellitus8 (36.4%)38 (30.9%)0.612
Prior myocardial infarction4 (18.2%)28 (22.8%)0.784
Prior PCI or CABG5 (22.7%)12 (9.8%)0.140
Chronic kidney disease4 (18.2%)20 (16.3%)0.762

Clinical characteristics
HR (bpm)98 (81,122)84 (72,98)0.011
MBP (mmHg)82.8 (66.2, 88.3)87.7 (70.4, 101.0)0.060
Cr (mol/L)89.1 (76.0, 133.8)85.7 (70.1, 104.8)0.215
TnI (ng/ml)1.11 (0.07, 10.07)0.07 (0.02, 1.45)0.010
BNP (pg/ml)973 (626,1889)618 (203,1052)0.004
LVEF (%)31.4 ± 8.336.7 ± 8.10.006
LVEDD (mm)60.5 (55.7, 73.2)58.0 (52.0, 64.0)0.065
EMATc16.5 (14.0, 20.2)12.7 (10.3, 15.0)<0.001

Data are presented as mean ± standard deviation for continuous variables with normal distribution, as median (interquartile range) for continuous variables with skewed distribution, and as frequency (percentage) for categorical variables.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.